我们产生的多数抗体是与病毒表面蛋白血凝素的球状头部结合的。
Most of the antibodies we produce bind to the globular heads of a surface protein on the virus called haemagglutinin.
然而,结合效率在不同毒株间存在差异,而且这种差异部分决定于血凝素蛋白中的受体结合位点。
However, binding efficiency varies between flu strains, and that variation is partly determined by the receptor-binding site (RBS) within the hemagglutinin protein.
报道还指出,EB治疗是通过与流感病毒血凝素结合,抑制病毒复制,从而阻止了流感病毒与细胞的黏附。
Eb treatment inhibited viral replication by binding to influenza virus hemagglutinin, thereby preventing attachment of influenza virus to cells, the report indicates.
应用推荐